Aside From The Recent Drug Failure, What Else Is Happening With Eli Lilly?
November 25, 2016 at 11:09 AM EST
Marc Goodman of UBS lowered his EPS estimates for Eli Lilly and Co (NYSE: LLY) after the company announced that its Alzheimer's drug ...